These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1092905)

  • 1. [Action mechanism of anti-tuberculosis drugs].
    Oizumi K
    Kekkaku; 1975 Mar; 50(3):23-4. PubMed ID: 1092905
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mode of action of kanamycin on Mycobacterium bovis, BCG (author's transl)].
    Oizumi K; Kumano N; Konno K; Oka S
    Kekkaku; 1974 Jan; 49(1):9-14. PubMed ID: 4597147
    [No Abstract]   [Full Text] [Related]  

  • 3. Selection of genes of Mycobacterium tuberculosis upregulated during residence in lungs of infected mice.
    Srivastava V; Jain A; Srivastava BS; Srivastava R
    Tuberculosis (Edinb); 2008 May; 88(3):171-7. PubMed ID: 18054522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Components of monitoring drug resistance of tuberculosis agent in the evaluation of effectiveness of the national tuberculosis control program].
    Popov SA; Dorozhkova IR; Medvedeva IM
    Probl Tuberk; 2001; (2):18-20. PubMed ID: 11490457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by means of Rifamycin SV susceptibility].
    Tsukamura M; Tsukamura S
    Igaku To Seibutsugaku; 1966 Jun; 72(6):350-2. PubMed ID: 4959327
    [No Abstract]   [Full Text] [Related]  

  • 6. Mode of action of kanamycin on Mycobacterium bovis BCG.
    Konno K; Oizumi K; Kumano N; Oka S
    Am Rev Respir Dis; 1973 Jul; 108(1):101-7. PubMed ID: 4577267
    [No Abstract]   [Full Text] [Related]  

  • 7. Mode of action of rifampin on mycobacteria. II. Biosynthetic studies on the inhibition of ribonucleic acid polymerase of Mycobacterium bovis BCG by rifampin and uptake of rifampin- 14 C by Mycobacterium phlei.
    Konno K; Oizumi K; Oka S
    Am Rev Respir Dis; 1973 Jun; 107(6):1006-12. PubMed ID: 4576356
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental studies of the antimycobacterial activity of Rifampicine].
    Nitti V; Catena E; Ninni A; Di Filippo A
    Arch Tisiol Mal Appar Respir; 1966 Nov; 21(11):867-910. PubMed ID: 4969274
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro experiment showing that chemotherapy of tuberculosis by aminoglycoside antibiotics may influence successive chemotherapy with rifampicin].
    Tsukamura M
    Kekkaku; 1991 Jan; 66(1):13-8. PubMed ID: 1901613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacodynamics of rifampicin--bacteriological and pharmacological action of rifampicin].
    Toyohara M
    Kekkaku; 1979 Dec; 54(12):576-8. PubMed ID: 392153
    [No Abstract]   [Full Text] [Related]  

  • 11. Laboratory diagnosis of antibiotic resistant Mycobacterium bovis within 48 h: a qualitative change in the approach to mycobacterial diseases in AIDS patients.
    Espinosa de los Monteros LE; Gomez-Mampaso E; Cobo J; Guerrero A; Baquero F; Blazquez J
    AIDS; 1997 May; 11(6):827-8. PubMed ID: 9143622
    [No Abstract]   [Full Text] [Related]  

  • 12. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
    Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mode of action of rifampicin on Mycobacterium tuberculosis].
    Konno K; Oizumi K; Hayashi I; Oka S
    Kekkaku; 1972 Aug; 47(8):255-60. PubMed ID: 4634136
    [No Abstract]   [Full Text] [Related]  

  • 14. [Correlation between the expression of Rv3286c, Rv2626c, Rv2031c, AND Rv3133c and the tolerance of Mycobacterium bovis BCG to rifampicin and metronidazole in different physiological conditions].
    Obozova TA; Artem'ev MI; Baranovskiĭ PM; Smetanina SE; Kiselev VI
    Probl Tuberk Bolezn Legk; 2005; (2):34-6. PubMed ID: 15881968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug susceptibility of Spanish Mycobacterium tuberculosis complex isolates from animals.
    Romero B; Aranaz A; Bezos J; Alvarez J; de Juan L; Tariq Javed M; Mateos A; Gómez-Mampaso E; Domínguez L
    Tuberculosis (Edinb); 2007 Nov; 87(6):565-71. PubMed ID: 17900988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Distribution of the range of natural sensitivity to antitubercular preparations in cultures of strains of mycobacterum BCG].
    Kulikova MF
    Antibiotiki; 1968 Jul; 13(7):642-7. PubMed ID: 4301383
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study of secondary tuberculostatic preparations in view of the resistance of mycobacteria to the primary drugs].
    Uvarova OA; Zemskova ZS; Stukalova BIa; Afanas'eva IuP
    Farmakol Toksikol; 1967; 30(4):474-7. PubMed ID: 4877410
    [No Abstract]   [Full Text] [Related]  

  • 19. Mode of action of antituberculous agents and ultrastructure of mycobacteria.
    Oka S; Yamaguchi J; Ariji F; Madokoro K; Kumano N
    Sci Rep Res Inst Tohoku Univ Med; 1971 Jul; 18(1):7-13. PubMed ID: 5005200
    [No Abstract]   [Full Text] [Related]  

  • 20. Results and therapeutic consequences of general resistance tests in tuberculosis of the urogenital system (author's transl).
    Gabler A
    Med Klin; 1973 Dec; 68(50):4648-52. PubMed ID: 4131488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.